Stay updated on the latest news and events

11.10 – 11.12

Incheon

South Korea

Hongene is thrilled to announce our participation in 2nd Annual World RNA-Based Therapeutics & Vaccines Summit.

Developing Safe & Efficacious mRNA, CircRNA & SaRNA Medicines With Smarter Design Optimization, Targeted Delivery & Scalable Manufacturing for Clinical & Commercial Readiness

South Korea’s mRNA ecosystem is rapidly advancing, fueled by progress from companies like GC Biopharma and EyeGene in clinical-stage vaccines. Also, with the growing momentum of ARPA-H initiatives focused on personalized mRNA cancer therapies and strong government backing continues to drive the development of safer, more effective RNA-based medicines.

Amid this innovation, the World RNA-Based Therapeutics & Vaccines Summit returns to South Korea for its second year, highlighting breakthroughs in mRNA design, therapeutic pipelines, targeted delivery, and solutions to key manufacturing and analytical challenges. This is your chance to de-risk your program strategies, unlock insights from international leaders, and forge networks to develop better RNA medicines for patients faster.

As Korean RNA and vaccine companies strive to establish partnerships, out-license their assets, or create co-development collaborations with global companies, join 80+ mRNA therapeutic and vaccine developers to differentiate your technology and learn how to generate meaningful data to open up the possibilities of future partnerships.

Welcome to visit us at site, booth #4. Let’s discuss how Hongene’s high-quality nucleic acid products and end-to-end RNA medicines solution can help make your project successful.